← Back to patent-cliff list
CAS 64-18-6
Formic acidN-Methylformamide-001
Codes: (II)91353-6-a, (III)122568-3-a, AZAC-010
Application context (from source-drug indications)
Back painDiclofenac Sodium/Eperisone HydrochlorideAttention deficit hyperactivity disorderClonidine Hydrochloride (Tris Pharma)HypertensionClonidine Hydrochloride (Tris Pharma)OsteoarthritisDiclofenac SodiumRheumatoid arthritisDiclofenac SodiumAnkylosing spondylitisDiclofenac SodiumCommon bile duct diseaseDiclofenac SodiumDental pulp diseaseDiclofenac SodiumArthritisDiclofenac Sodium幼年型粒单核细胞白血病AzacitidineAcute myeloid leukaemiaAzacitidineMyelodysplastic syndromeAzacitidineChronic myeloid leukaemiaAzacitidineChronic myelomonocytic leukaemiaAzacitidine脑性瘫痪Azacitidine
Source drugs (routes using this intermediate)
| Drug | Tier | Expiry |
|---|---|---|
| Diclofenac Sodium/Eperisone Hydrochloride | Tier C — Watch / trade | - |
| Clonidine Hydrochloride (Tris Pharma) | Tier C — Watch / trade | - |
| Diclofenac Sodium | Tier C — Watch / trade | - |
| Azacitidine | Tier C — Watch / trade | - |
Position in synthesis routes (up/downstream chain)
Ordered by route registration; left → right is the synthesis direction. The highlighted node is the current CAS; others link to their own profiles.
4-amino-1,3,5-triazin-2(1H)-one→N-(trimethylsilyl)-4-((trimethylsilyl)oxy)-1,3,5-triazin-2-amine→(2S,3R,4R,5R)-5-(acetoxymethyl)tetrahydrofuran-2,3,4-triyl triacetate→AZAC-009→N-Methylformamide-001→1-(diaminomethylene)urea→(2R,3R,4R,5R)-2-(acetoxymethyl)-5-(4-amino-2-oxo-1,3,5-triazin-1(2H)-yl)tetrahydrofuran-3,4-diyl diacetate
Intermediates available on this site
No listed intermediates for this target yet — send an RFQ directly and it will enter our matching pool.
This is a CAS-level registry record: registrations across routes are merged. Supplier offers and buyer demands will be matched on this CAS as the primary key.